Aligos Therapeutics (ALGS) Q3 2024 Earnings Report

485 Followers

ALGS Q3 2024 EPS Results

Actual EPS-$3.07

Consensus EPS-$2.16

Beat/MissMissed by -$0.91

One Year Ago EPS-$10.25

Actual Revenue$1.27M

Expected Revenue$333.00K

Beat/MissBeat by +$936.00K

YoY Revenue Growth-60.82%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

ALGS Upcoming Earnings

Aligos Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 11, 2027	2026 (Q4)	- / -	-1.91	―
Aug 06, 2026	2026 (Q2)	-1.09 / -0.14	-1.53	90.85% (+1.39)
May 07, 2026	2026 (Q1)	-2.21 / -2.21	-2.11	-4.74% (-0.10)
Mar 05, 2026	2025 (Q4)	-2.49 / -1.91	-13.08	85.40% (+11.17)
Nov 06, 2025	2025 (Q3)	-1.90 / -3.04	-3.07	0.98% (+0.03)
Aug 06, 2025	2025 (Q2)	-2.36 / -1.53	0.75	-304.00% (-2.28)
May 06, 2025	2025 (Q1)	-2.98 / -2.11	-5.5	61.64% (+3.39)
Mar 10, 2025	2024 (Q4)	-2.50 / -13.08	-5.5	-137.82% (-7.58)
Nov 06, 2024	2024 (Q3)	-2.16 / -3.07	-10.25	70.05% (+7.18)
Aug 06, 2024	2024 (Q2)	-4.00 / 0.75	-10.75	106.98% (+11.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed